CLOSED
NIFTY 5022,453.30+0.98%SENSEX74,235.62+1.24%BANK NIFTY48,892.15+1.45%NIFTY IT35,124.80-0.52%NIFTY MIDCAP52,487.25+0.87%NIFTY 5022,453.30+0.98%SENSEX74,235.62+1.24%BANK NIFTY48,892.15+1.45%NIFTY IT35,124.80-0.52%NIFTY MIDCAP52,487.25+0.87%

Search & Analyze

Popular Searches

Abbott India Ltd.

HealthcarePharmaceuticals & Drugs
www.abbott.co.inBSE: 500488NSE: ABBOTINDIA
₹25,800.10BSE0.17%

07 Sep, 4:01 PM

₹25,800.10
₹55.03K Cr
0.00
0.00
37.45%
₹26,120.00
₹25,775.60
₹31,650.00
₹25,164.00

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA.

SUNPHARMA

1,899.8037.694,55,825.660.842,901.2326.53%15,299.8810.46%19.11
DIVI'S LAB.

DIVISLAB

9,305.0084.452,47,018.510.32902.0065.50%3,080.0027.80%21.51
TORRENT PHAR

TORNTPHARM

4,913.0085.681,86,874.730.77566.003.28%4,921.0054.85%19.27
ZYDUSLIFE

ZYDUSLIFE

1,155.0025.531,15,211.690.09990.20-34.90%8,017.0021.96%21.39
CIPLA LTD.

CIPLA

1,395.9533.461,12,773.000.93785.55-39.18%7,119.282.33%16.00
LAURUSLABS

LAURUSLABS

1,868.2592.321,00,943.830.11362.07123.94%2,026.3129.10%18.20
LUPIN LTD.

LUPIN

2,105.0017.4196,254.460.861,416.9816.01%8,276.8932.04%28.86
Abbott India Ltd.

ABBOTINDIA

25,800.100.0055,028.152.5349.12

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars

Profit & Loss

consolidated figures in ₹ Crores · Annual

ParticularsFY 2000-01 (Nov)
No of Months11.00
INCOME :
371.50
Less: Excise Duty15.19
356.31
EXPENDITURE :
Increase/Decrease in Stock5.40
Raw Material Consumed177.00
Power & Fuel Cost2.92
Employee Cost21.63
Other Manufacturing Expenses16.42
General and Administration Expenses9.79
Selling and Distribution Expenses63.11
Miscellaneous Expenses9.59
305.87
Operating Profit (Excl OI)50.44
20.48
70.93
Interest0.12
PBDT70.81
4.48
Profit Before Taxation & Exceptional Items66.33
66.33
Provision for Tax16.67
49.66
Consolidated Net Profit49.66
Adjustments to PAT2.82
Profit Balance B/F52.47
Appropriations104.95
Equity Dividend %100.00%
30.66
Adjusted EPS30.66

Balance Sheet

consolidated figures in ₹ Crores

ParticularsFY 2000-01 (Nov)
16.20
Total Reserves116.41
Reserve excluding Revaluation Reserve116.41
Revaluation reserve0.00
132.61
Unsecured Loans2.66
Deferred Tax Assets / Liabilities9.16
Total Non-Current Liabilities11.82
Trade Payables62.44
Other Current Liabilities1.33
Short Term Provisions31.43
Total Current Liabilities95.21
Total Liabilities239.63
Gross Block72.23
Less: Accumulated Depreciation31.25
Net Block40.98
Capital Work in Progress0.72
Non Current Investments96.78
Long Term Investment96.78
Total Non-Current Assets138.48
Currents Investments0.00
Inventories57.39
Sundry Debtors22.87
Cash and Bank10.78
Short Term Loans and Advances10.11
Total Current Assets101.15
Net Current Assets (Including Current Investments)5.95
Total Assets239.63
Total Debt2.66
81.86
Adjusted Book Value81.86

Cash Flow

consolidated figures in ₹ Crores

ParticularsFY 2000-01 (Nov)
No of Months11.00
66.33
Adjustment-2.30
Changes In working Capital-13.95
Cash Flow after changes in Working Capital50.08
Cash Flow from Operating Activities35.49
Cash Flow from Investing Activities0.55
Cash Flow from Financing Activitie-27.02
Net Cash Inflow / Outflow9.02
Opening Cash & Cash Equivalents1.48
Closing Cash & Cash Equivalent10.50

Ratios

Profitability

37.45
49.12
20.72
13.58
13.37

Leverage & Liquidity

0.02
1.06
552.36

Returns

2.53
1.55

Shareholding Pattern

Numbers in percentages

ParticularsJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
74.9974.9974.9974.9974.9974.9974.9974.9974.99
8.999.169.179.089.359.279.189.199.16
16.0215.8515.8415.9315.6615.7515.8315.8115.85
25.0125.0125.0125.0125.0125.0125.0125.0125.01
No. of Shareholders71,58869,44967,89269,93467,58471,19975,80175,86678,320

Corporate Actions

Showing: All
DateTypeDetailsEx-DateRecord Date
2026-08-04Board Meeting Quarterly Results
2026-07-20AGM
2026-05-11Ex DividendRs.131.0000 per share(1310%)Special Dividend2026-07-242026-07-24

Insider Trading

DatePersonCategoryTransaction TypeSharesValue (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Abbott India Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Company Information

Industry

Pharmaceuticals & Drugs

Founded

1944

Headquarters

Mumbai, Maharashtra

Group

Abbott India - MNC

Chairman

Sudarshan Jain

Managing Director

Kartik Rajendran

Company Secretary

Sangeeta Shetty

Face Value

₹10

CIN

L24239MH1944PLC007330

Key Management

10 members across the board and senior leadership

Kartik Rajendran

Managing Director

Munir Shaikh

Chairman

Sudarshan Jain

Chairman

Shalini Kamath

Non Executive Independent Director

Neeraj Jain

Non Executive Independent Director

Vivek Mohan

Non Executive Director

Kaiyomarz Marfatia

Non Executive Director

Sangeeta Shetty

Company Secretary & Compliance Officer

James Wenner

Non Executive Director

Darshan Gada

Non Executive Director

ABBOTINDIA Latest News

News

3 of 3 articles
EQUITY13 May 2026 · 15:34

Abbott India informs about press release

EQUITY13 May 2026 · 12:36

Abbott India informs about notice of postal ballot

EQUITY11 May 2026 · 22:12

Abbott India reports Profit after tax of Rs 3949.30 Mln, in the March 2026 quarter

ABBOTINDIA

₹25,800.10

-0.17%